Arcadis – Improving PFAS knowledge with Australian technology

Arcadis signed a Heads of Agreement with EVOCRA, enabling an exclusive commercial negotiating period within which the parties will finalize a license agreement for sole rights to the EVOCRA technology for PFAS solutions. This technology, which has already been proven at commercial scale on projects in Australia, will be a welcome addition to Arcadis’ existing suite of PFAS solutions, allowing Arcadis to continue to offer a differentiated solution for clients globally.

To celebrate that Arcadis environment director Marc Raessen will open the stock exchange. 

PFAS, or per- and poly-fluorinated alkyl substances, were incorporated in commercial, industrial and consumer products, including textile coatings, stain repellents, electronics and mist suppressants. PFAS were also components of firefighting foams known as Aqueous Film Forming Foam (AFFF). In recent years, under increasing scientific and regulatory scrutiny and community awareness, more is being understood about PFAS toxicity, environmental persistence, aquifer mobility and the potential for this emerging contaminant to bioaccumulate in natural environments and enter the food chain.

Arcadis is at the forefront of a global effort to remove PFAS from impacted sites and environments, with over 75 projects in their portfolio, representing over 300 individual sites in 12 countries. This deal will continue Arcadis’ push to achieve greater market share within the PFAS space and provide their clients with a unique and innovative solution that can be used on its own and/or in conjunction with other technologies to remove PFAS from impacted sources. In the beginning of 2020 Arcadis will start tests in The Netherlands tests with the EVOCRA technology.